Vaccine-induced humoral and cellular immunity against SARS-CoV-2 at 6 months post BNT162b2 vaccination
Hideaki Kato, Kei Miyakawa, Norihisa Ohtake, Yutaro Yamaoka, Satoshi Yajima, Etsuko Yamazaki, Tomoko Shimada, Atsushi Goto, Hideaki Nakajima, Akihide Ryo
doi: https://doi.org/10.1101/2021.10.30.21265693
Hideaki Kato
1Infection Prevention and Control Department, Yokohama City University Hospital, Yokohama, Japan
2Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japan
Kei Miyakawa
3Department of Microbiology, Yokohama City University School of Medicine, Yokohama, Japan
Norihisa Ohtake
4Bioscience Division, Research and Development Department, Tosoh Corporation, Tokyo Research Center, Kanagawa, Japan
5Advanced Medical Research Center, Yokohama City University, Yokohama, Japan
Yutaro Yamaoka
3Department of Microbiology, Yokohama City University School of Medicine, Yokohama, Japan
6Life Science Laboratory, Technology and Development Division, Kanto Chemical Co, Inc., Isehara, Japan
Satoshi Yajima
7Clinical Laboratory Department, Yokohama City University Hospital, Yokohama, Japan
Etsuko Yamazaki
7Clinical Laboratory Department, Yokohama City University Hospital, Yokohama, Japan
Tomoko Shimada
8Nursing Department, Yokohama City University Hospital, Yokohama, Japan
Atsushi Goto
9Department of Health Data Science, Yokohama City University Graduate School of Data Science, Yokohama, Japan
Hideaki Nakajima
2Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japan
Akihide Ryo
3Department of Microbiology, Yokohama City University School of Medicine, Yokohama, Japan
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Posted October 30, 2021.
Vaccine-induced humoral and cellular immunity against SARS-CoV-2 at 6 months post BNT162b2 vaccination
Hideaki Kato, Kei Miyakawa, Norihisa Ohtake, Yutaro Yamaoka, Satoshi Yajima, Etsuko Yamazaki, Tomoko Shimada, Atsushi Goto, Hideaki Nakajima, Akihide Ryo
medRxiv 2021.10.30.21265693; doi: https://doi.org/10.1101/2021.10.30.21265693
Vaccine-induced humoral and cellular immunity against SARS-CoV-2 at 6 months post BNT162b2 vaccination
Hideaki Kato, Kei Miyakawa, Norihisa Ohtake, Yutaro Yamaoka, Satoshi Yajima, Etsuko Yamazaki, Tomoko Shimada, Atsushi Goto, Hideaki Nakajima, Akihide Ryo
medRxiv 2021.10.30.21265693; doi: https://doi.org/10.1101/2021.10.30.21265693
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2931)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12734)
- Forensic Medicine (12)
- Gastroenterology (827)
- Genetic and Genomic Medicine (4578)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2914)
- Health Policy (1069)
- Hematology (388)
- HIV/AIDS (924)
- Medical Education (424)
- Medical Ethics (115)
- Nephrology (468)
- Neurology (4345)
- Nursing (236)
- Nutrition (638)
- Oncology (2266)
- Ophthalmology (645)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (500)
- Pediatrics (1196)
- Primary Care Research (495)
- Public and Global Health (6932)
- Radiology and Imaging (1526)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (487)
- Toxicology (60)
- Transplantation (210)
- Urology (180)